NEUROPATHIX, INC. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3e3e786c-095f-4603-bf8c-57bf007acf33/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $183.5k | 2021-01-01 – 2021-12-31 | evidence 0001607062-22-000284 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001607062-21-000063 |
| FY 2019 | $126.0k | 2019-01-01 – 2019-12-31 | evidence 0001607062-20-000083 |
| FY 2018 | $173.9k | 2018-01-01 – 2018-12-31 | evidence 0001078782-19-000306 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001078782-19-000306 |
| FY 2016 | $35.0k | 2016-01-01 – 2016-12-31 | evidence 0001615999-17-000003 |
| FY 2015 | $145.0k | 2015-01-01 – 2015-12-31 | evidence 0001615999-17-000003 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NEUROPATHIX, INC. — all facts · Net Income · Operating Income